31 Mar 2021
Assets106.31
Total Income183.78
Profit After Tax30.59
NET Worth88.58
Total Borrowing0.35
Open · Close · Listing
Valiant Laboratories is a Mainboard IPO with an issue size of ₹152.46 crore, proposed for listing on BSE, NSE. The issue structure includes a fresh issue of ₹152.46 crore.
| Object | Amount |
|---|---|
| Investment in VASPL for partfinancing its capital expenditure requirements in relation to the setting up of the Proposed Facility | ₹80.00 Cr |
| Investment in VASPL for funding its working capital requirements; and | ₹45.00 Cr |
| General corporate purposes | ₹9.32 Cr |
| Total | ₹134.32 Cr |
| KPI |
|---|
| ROE |
| ROCE |
| Debt / Equity |
| RoNW |
| PAT Margin |
| Expense | Amount |
|---|---|
| BRLM fees and commissions (including any underwriting commission, brokerage and selling commission) | ₹6.08 Cr |
| Commission/processing fee for SCSBs, Sponsor Bank(s) and Bankers to the Issue. Brokerage, underwriting commission and selling commission and bidding charges for members of the Syndicate, Registered Brokers, RTAs and CDPs | ₹1.01 Cr |
| Fees payable to Registrar to the issue | ₹0.10 Cr |
| Others - Listing fees, SEBI filing fees, upload fees, BSE and NSE processing fees, book building software fees and other regulatory expenses | ₹1.49 Cr |
| - Printing and stationery | ₹1.00 Cr |
| - Fee payable to legal counsels | ₹0.30 Cr |
| - Advertising and marketing | ₹7.12 Cr |
| Miscellaneous | ₹1.04 Cr |